Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study

Authors: Erica L. Mayer, Amylou C. Dueck, Miguel Martín, Gábor Rubovszky, Harold J. Burstein, M. Bellet-Ezquerra, Kathy D. Miller, Nicholas Zdenkowski, Eric P. Winer, Georg Pfeiler, Matthew P. Goetz, Manuel Ruíz‐Borrego, D. Mark Anderson, Zbigniew Nowecki, Sibylle Loibl, Stacy Moulder, Alistair Ring, Florian Fitzal, Tiffany A. Traina, Arlene Chan, Hope S. Rugo, Julie Lemieux, Fernando Henao, Alan P. Lyss, Silvia Antolín, Antonio C. Wolff, Marcus Vetter, Daniel Egle, Patrick G. Morris, Eleftherios P. Mamounas, Miguel Gil‐Gil, Aleix Prat, Hannes Fohler, Otto Metzger, Magdalena Schwarz, Carter DuFrane, Debora Fumagalli, Kathy Puyana Theall, Dongrui R. Lu, Cynthia Huang Bartlett, María Koehler, Christian Fesl, Angela DeMichele, Michael Gnant - The Lancet 2021 cited by 255